We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$6.71B
AUM Growth
+$2.5B
(+59%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
30.61%
Top 10 Holdings %
Top 10 Hldgs %
14.85%
Holding
2,565
New
44
Increased
937
Reduced
347
Closed
1,235
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.8M |
| 2 |
Microsoft
MSFT
|
+$58.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$56.5M |
| 4 |
ExxonMobil
XOM
|
+$46.3M |
| 5 |
Chevron
CVX
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$4.89M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$3.48M |
| 3 |
NYX
NYSE EURONEXT INC
NYX
|
+$3.27M |
| 4 |
CoStar Group
CSGP
|
+$2.8M |
| 5 |
VPHM
VIROPHARMA INC
VPHM
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.32% |
| 2 | Technology | 15.24% |
| 3 | Healthcare | 12.35% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RKUS
1276
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $153K | ﹤0.01% |
10,788
-21,912
| -67% | -$322K |
|
|
SVA
1277
DELISTED
Sinovac Biotech, Ltd
SVA
| $148K | ﹤0.01% |
24,134
+4,786
| +25% | +$28.8K |
|
1278
Verastem
VSTM
$532M
| $143K | ﹤0.01% |
1,045
+134
| +15% | +$17.6K |
|
|
AMRN
1279
Amarin Corp
AMRN
$284M
| $142K | ﹤0.01% |
3,604
+1,098
| +44% | +$56.8K |
|
1280
Graphic Packaging
GPK
$3.26B
| $142K | ﹤0.01% |
14,776
-117,839
| -89% | -$1.03M |
|
|
RGLS
1281
DELISTED
Regulus Therapeutics
RGLS
| $141K | ﹤0.01% |
+159
| New | +$137K |
|
|
CSG
1282
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $141K | ﹤0.01% |
18,389
-131,821
| -88% | -$1.12M |
|
|
XNPT
1283
DELISTED
XENOPORT, INC.
XNPT
| $140K | ﹤0.01% |
24,268
-20,006
| -45% | -$108K |
|
|
SQNM
1284
DELISTED
SEQUENOM INC NEW
SQNM
| $139K | ﹤0.01% |
59,366
-53,891
| -48% | -$128K |
|
|
SCLN
1285
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $138K | ﹤0.01% |
27,381
-25,908
| -49% | -$125K |
|
|
BRCD
1286
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $137K | ﹤0.01% |
+15,413
| New | +$129K |
|
|
TIVO
1287
DELISTED
TIVO INC
TIVO
| $134K | ﹤0.01% |
10,233
-70,257
| -87% | -$909K |
|
1288
Rithm Capital
RITM
$5.09B
| $131K | ﹤0.01% |
9,837
-70,518
| -88% | -$909K |
|
|
BEE
1289
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $130K | ﹤0.01% |
13,725
-100,902
| -88% | -$893K |
|
|
VG
1290
DELISTED
Vonage Holdings Corporation
VG
| $130K | ﹤0.01% |
38,934
-82,450
| -68% | -$277K |
|
1291
Rigel Pharmaceuticals
RIGL
$680M
| $128K | ﹤0.01% |
4,508
-4,097
| -48% | -$120K |
|
|
SD
1292
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $127K | ﹤0.01% |
20,975
+5,217
| +33% | +$31.2K |
|
|
MDR
1293
DELISTED
McDermott International
MDR
| $126K | ﹤0.01% |
4,600
+1,177
| +34% | +$27.5K |
|
1294
Entegris
ENTG
$19.7B
| $125K | ﹤0.01% |
10,782
-77,638
| -88% | -$820K |
|
1295
Curis
CRIS
$9.53M
| $124K | ﹤0.01% |
22
-18
| -45% | -$123K |
|
1296
Supernus Pharmaceuticals
SUPN
$2.68B
| $121K | ﹤0.01% |
16,051
-4,220
| -21% | -$29.5K |
|
1297
Opko Health
OPK
$921M
| $120K | ﹤0.01% |
14,220
-105,045
| -88% | -$1.06M |
|
|
CCXI
1298
DELISTED
ChemoCentryx, Inc.
CCXI
| $119K | ﹤0.01% |
20,629
+5,099
| +33% | +$26.3K |
|
|
TQNT
1299
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $119K | ﹤0.01% |
14,248
-92,777
| -87% | -$740K |
|
|
CAA
1300
DELISTED
CalAtlantic Group, Inc.
CAA
| $118K | ﹤0.01% |
2,601
-16,872
| -87% | -$672K |
|
Similar funds
ProShare Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, ProShare Advisors held 2,565 positions worth $6.71B, up 59% from $4.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
ProShare Advisors deployed $2.05B of net new capital in Q4 2013, opening 44 new positions and adding to 937 existing holdings. Its largest new stake was VEON: 13,524 shares worth $4.38M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was CoStar Group, an estimated $2.8M trimmed.
- ProShare Advisors's largest Q4 2013 buy was VEON: 13,524 shares worth $4.38M.
- ProShare Advisors added most to Apple in Q4 2013, an estimated $92.8M increase.
- ProShare Advisors's biggest Q4 2013 reduction was CoStar Group, cutting an estimated $2.8M.
- ProShare Advisors fully exited DELL INC in Q4 2013, selling an estimated $4.89M.
- ProShare Advisors's ten largest holdings make up 15% of its $6.71B portfolio in Q4 2013.
- ProShare Advisors opened 44 new positions and closed 1,235 in Q4 2013.
- ProShare Advisors's portfolio value rose 59% quarter-over-quarter to $6.71B.
Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.